transgenics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : transgenics

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who started this subject	9/8/2000 6:44:55 AM
From: nigel bates	of 41

LONDON, Sept 8 (Reuters) - British biotechnology firm PPL Therapeutics Plc (LSE: PTH.L - news) said on Friday it had signed an agreement with an unidentified U.S.-based biotechnology company to study transgenic production of a novel peptide which inhibits excess tissue formation. The study will initially concentrate on rabbit milk. "This is the fourth peptide agreement PPL has signed since demonstrating successful proof of principle of its proprietary peptide technology in its calcitonin programme," PPL said in a statement.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next